These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 10202930)

  • 1. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB.
    Wang CY; Cusack JC; Liu R; Baldwin AS
    Nat Med; 1999 Apr; 5(4):412-7. PubMed ID: 10202930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inducible chemoresistance to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothe cin (CPT-11) in colorectal cancer cells and a xenograft model is overcome by inhibition of nuclear factor-kappaB activation.
    Cusack JC; Liu R; Baldwin AS
    Cancer Res; 2000 May; 60(9):2323-30. PubMed ID: 10811101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IkappaBalpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomas.
    Tietze MK; Wuestefeld T; Paul Y; Zender L; Trautwein C; Manns MP; Kubicka S
    Cancer Gene Ther; 2000 Oct; 7(10):1315-23. PubMed ID: 11059688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of chemotherapeutic agents following antagonism of nuclear factor kappa B in human gliomas.
    Weaver KD; Yeyeodu S; Cusack JC; Baldwin AS; Ewend MG
    J Neurooncol; 2003 Feb; 61(3):187-96. PubMed ID: 12675310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfer of IkappaBalpha gene increase the sensitivity of paclitaxel mediated with caspase 3 activation in human lung cancer cell.
    Osaki S; Nakanishi Y; Takayama K; Pei XH; Ueno H; Hara N
    J Exp Clin Cancer Res; 2003 Mar; 22(1):69-75. PubMed ID: 12725325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducible nuclear factor-kappaB activation contributes to chemotherapy resistance in gastric cancer.
    Camp ER; Li J; Minnich DJ; Brank A; Moldawer LL; MacKay SL; Hochwald SN
    J Am Coll Surg; 2004 Aug; 199(2):249-58. PubMed ID: 15275881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the transcription factor nuclear factor-kappa B by adenoviral-mediated expression of I kappa B alpha M results in tumor cell death.
    Feig BW; Lu X; Hunt KK; Shan Q; Yu D; Pollock R; Chiao P
    Surgery; 1999 Aug; 126(2):399-405. PubMed ID: 10455913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient adenoviral transfer of NF-kappaB inhibitor sensitizes melanoma to tumor necrosis factor-mediated apoptosis.
    Bakker TR; Reed D; Renno T; Jongeneel CV
    Int J Cancer; 1999 Jan; 80(2):320-3. PubMed ID: 9935217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated expression of a dominant negative mutant of p65/RelA inhibits proinflammatory gene expression in endothelial cells without sensitizing to apoptosis.
    Soares MP; Muniappan A; Kaczmarek E; Koziak K; Wrighton CJ; Steinhäuslin F; Ferran C; Winkler H; Bach FH; Anrather J
    J Immunol; 1998 Nov; 161(9):4572-82. PubMed ID: 9794384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of p21Waf1/Cip1 by TNFalpha requires NF-kappaB activity and antagonizes apoptosis in Ewing tumor cells.
    Javelaud D; Wietzerbin J; Delattre O; Besançon F
    Oncogene; 2000 Jan; 19(1):61-8. PubMed ID: 10644980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IkappaBalpha gene transfer is cytotoxic to squamous-cell lung cancer cells and sensitizes them to tumor necrosis factor-alpha-mediated cell death.
    Batra RK; Guttridge DC; Brenner DA; Dubinett SM; Baldwin AS; Boucher RC
    Am J Respir Cell Mol Biol; 1999 Aug; 21(2):238-45. PubMed ID: 10423407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-mediated inhibition of NF-kappaB confers chemo-sensitization and apoptosis in prostate cancer cells.
    Flynn V; Ramanitharan A; Moparty K; Davis R; Sikka S; Agrawal KC; Abdel-Mageed AB
    Int J Oncol; 2003 Aug; 23(2):317-23. PubMed ID: 12851680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin.
    Arlt A; Vorndamm J; Breitenbroich M; Fölsch UR; Kalthoff H; Schmidt WE; Schäfer H
    Oncogene; 2001 Feb; 20(7):859-68. PubMed ID: 11314019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of nuclear factor-κB enhances the antitumor effect of tumor necrosis factor-α gene therapy for hepatocellular carcinoma in mice.
    Haruki K; Shiba H; Fujiwara Y; Furukawa K; Iwase R; Uwagawa T; Misawa T; Ohashi T; Yanaga K
    Surgery; 2013 Sep; 154(3):468-78. PubMed ID: 23972653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calpain 2-dependent IκBα degradation mediates CPT-11 secondary resistance in colorectal cancer xenografts.
    Fenouille N; Grosso S; Yunchao S; Mary D; Pontier-Bres R; Imbert V; Czerucka D; Caroli-Bosc FX; Peyron JF; Lagadec P
    J Pathol; 2012 May; 227(1):118-29. PubMed ID: 22069124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ATM protein is required for sustained activation of NF-kappaB following DNA damage.
    Piret B; Schoonbroodt S; Piette J
    Oncogene; 1999 Apr; 18(13):2261-71. PubMed ID: 10327072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulindac enhances tumor necrosis factor-alpha-mediated apoptosis of lung cancer cell lines by inhibition of nuclear factor-kappaB.
    Berman KS; Verma UN; Harburg G; Minna JD; Cobb MH; Gaynor RB
    Clin Cancer Res; 2002 Feb; 8(2):354-60. PubMed ID: 11839649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenoviral gene transfer of ABIN-1 protects mice from TNF/galactosamine-induced acute liver failure and lethality.
    Wullaert A; Wielockx B; Van Huffel S; Bogaert V; De Geest B; Papeleu P; Schotte P; El Bakkouri K; Heyninck K; Libert C; Beyaert R
    Hepatology; 2005 Aug; 42(2):381-9. PubMed ID: 16025521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization of tumor cells toward chemotherapy: enhancing the efficacy of camptothecin with imidazolines.
    Sharma V; Lansdell TA; Peddibhotla S; Tepe JJ
    Chem Biol; 2004 Dec; 11(12):1689-99. PubMed ID: 15610853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.
    Duffey DC; Chen Z; Dong G; Ondrey FG; Wolf JS; Brown K; Siebenlist U; Van Waes C
    Cancer Res; 1999 Jul; 59(14):3468-74. PubMed ID: 10416612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.